Understanding the function of CD1-restricted T cells

Nature Immunology

Volumn 4, Issue 6, 2003, Pages 517-523

  Vincent, Michael S ^a   Gumperz, Jenny E ^a   Brenner, Michael B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD1 ANTIGEN; LIPID;

ANTIGEN BINDING; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; AUTOIMMUNITY; CELL COMPARTMENTALIZATION; CELL FUNCTION; DENDRITIC CELL; EFFECTOR CELL; ENDOSOME; FOREIGN BODY; HELPER CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1; AUTOIMMUNITY; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; MODELS, MOLECULAR; MYCOLIC ACIDS; T-LYMPHOCYTES;

EID: 0038044636     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni0603-517     Document Type: Review

References (110)

1. Zeng, Z. et al. Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science 277, 339-345 (1997).
2. Gadola, S.D. et al. Structure of human CD1b with bound ligands at 2.3 Å, a maze for alkyl chains. Nat. Immunol. 3, 721-726 (2002).
3. Calabi, F., Jarvis, J.M., Martin, L. & Milstein, C. Two classes of CD1 genes. Eur. J. Immunol. 19, 285-292 (1989).
4. Blumberg, R.S. et al. Expression of a nonpolymorphic MHC class I-like molecule, CD1D, by human intestinal epithelial cells. J. Immunol. 147, 2518-2524 (1991).
5. Brossay, L. et al. Mouse CD1 is mainly expressed on hemopoietic-derived cells. J. Immunol. 159, 1216-1224 (1997).
6. Spada, F.M. et al. Low expression level but potent antigen presenting function of CD1d on monocyte lineage cells. Eur. J. Immunol. 30, 3468-3477 (2000).
7. Martin, L.H., Calabi, F. & Milstein, C. Isolation of CD1 genes: a family of major histocompatibility complex-related differentiation antigens. Proc. Natl. Acad. Sci. USA 83, 9154-9158 (1986).
8. Balk, S.P., Bleicher, P.A. & Terhorst, C. Isolation and expression of cDNA encoding the murine homologues of CD1. J. Immunol. 146, 768-774 (1991).
9. Sugita, M., Porcelli, S.A. & Brenner, M.B. Assembly and retention of CD1b heavy chains in the endoplasmic reticulum. J. Immunol. 159, 2358-2365 (1997).
10. Kang, S.J. & Cresswell, P. Calnexin, calreticulin, and ERp57 cooperate in disulfide bond formation in human CD1d heavy chain. J. Biol. Chem. 277, 44838-44844 (2002).
11. Joyce, S. et al. Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. Science 279, 1541-1544 (1998).
12. De Silva, A.D. et al. Lipid protein interactions: the assembly of CD1d1 with cellular phospholipids occurs in the endoplasmic reticulum. J. Immunol. 168, 723-733 (2002).
13. Sugita, M. et al. Separate pathways for antigen presentation by CD1 molecules. Immunity 11, 743-752 (1999).
14. Briken, V., Jackman, R.M., Dasgupta, S., Hoening, S. & Porcelli, S.A. Intracellular trafficking pathway of newly synthesized CD1b molecules. EMBO J. 21, 825-834 (2002).
15. Jackman, R.M. et al. The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens. Immunity 8, 341-351 (1998).
16. Sugita, M. et al. Failure of trafficking and antigen presentation by CD1 in AP-3-deficient cells. Immunity 16, 697-706 (2002).
17. Chiu, Y.H. et al. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J. Exp. Med. 189, 103-110 (1999).
18. + T cells. Nature 372, 691-694 (1994).
19. Sieling, P.A. et al. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 269, 227-230 (1995).
20. Moody, D.B. et al. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science 278, 283-286 (1997).
21. Moody, D.B. et al. CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature 404, 884-888 (2000).
22. Grant, E.P. et al. Molecular recognition of lipid antigens by T cell receptors. J. Exp. Med. 189, 195-205 (1999).
23. Grant, E.P. et al. Fine specificity of TCR complementarity-determining region residues and lipid antigen hydrophilic moieties in the recognition of a CD1-lipid complex. J. Immunol. 168, 3933-3940 (2002).
24. - cytolytic T lymphocytes. Nature 341, 447-450 (1989).
25. + T lymphocytes. Science 268, 863-865 (1995).
26. - T cells. J. Exp. Med. 186, 109-120 (1997).
27. van Der Vliet, H.J. et al. Human natural killer T cells acquire a memory-activated phenotype before birth. Blood 95, 2440-2442 (2000).
28. + NKT cells in germ-free mice. Eur. J. Immunol. 30, 620-625 (2000).
29. Ernst, B., Lee, D.S., Chang, J.M., Sprent, J. & Surh, C.D. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity 11, 173-181 (1999).
30. + T cells, but affect their long-term life span. Immunity 5, 217-228 (1996).
31. Stefanova, I., Dorfman, J.R. & Germain, R.N. Self-recognition promotes the foreign antigen sensitivity of naive T lymphocytes. Nature 420, 429-434 (2002).
32. Spada, F.M. et al. Self-recognition of CD1 by γ/δ T cells: implications for innate immunity. J. Exp. Med. 191, 937-948 (2000).
33. Shamshiev, A. et al. Self glycolipids as T-cell autoantigens. Eur. J. Immunol. 29, 1667-1675 (1999).
34. Shamshiev, A. et al. Presentation of the same glycolipid by different CD1 molecules. J. Exp. Med. 195, 1013-1021 (2002).
35. Gumperz, J.E. et al. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12, 211-221 (2000).
36. - T cells in mice and humans. J. Exp. Med. 180, 1097-1106 (1994).
37. + NK T Cells. J. Immunol. 166, 1755-1762 (2001).
38. Matsuda, J.L. et al. Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor β repertoire and small clone size. Proc. Natl. Acad. Sci. USA 98, 12636-12641 (2001).
39. Yokoyama, W.M. et al. cDNA cloning of mouse NKR-P1 and genetic linkage with LY-49. Identification of a natural killer cell gene complex on mouse chromosome 6. J. Immunol. 147, 3229-3236 (1991).
40. Park, S.H. et al. The mouse CD1d-restricted repertoire is dominated by a few autore-active T cell receptor families. J. Exp. Med. 193, 893-904 (2001).
41. + T cells in major histocompatibility complex class II-deficient mice. J. Exp. Med. 182, 993-1004 (1995).
42. h2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses. J. Immunol. 167, 5531-5534 (2001).
43. α14 NKT cells by glycosylceramides. Science 278, 1626-1629 (1997).
44. Matsuda, J.L. et al. Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 192, 741-754 (2000).
45. Benlagha, K., Weiss, A., Beavis, A., Teyton, L. & Bendelac, A. In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J. Exp. Med. 191, 1895-1903 (2000).
46. Gumperz, J.E., Miyake, S., Yamamura, T. & Brenner, M.B. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195, 625-636 (2002).
47. α24 natural killer T cells. J. Exp. Med. 195, 637-641 (2002).
48. - T lymphocytes to a microbial antigen. Nature 360, 593-597 (1992).
49. + αβ T cell pool. J. Immunol. 162, 366-371 (1999).
50. + T cells in the CD1-restricted repertoire: derivation of mycobacteria-reactive T cells from leprosy lesions. J. Immunol. 164, 4790-4796 (2000).
51. Vincent, M.S. et al. CD1-dependent dendritic cell instruction. Nat. Immunol. 3, 1163-1168 (2002).
52. Cella, M., Engering, A., Pinet, V., Pieters, J. & Lanzavecchia, A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 388, 782-787 (1997).
53. Pierre, P. et al. Developmental regulation of MHC class II transport in mouse dendritic cells. Nature 388, 787-792 (1997).
54. Cao, X. et al. CD1 molecules efficiently present antigen in immature dendritic cells and traffic independently of MHC class II during dendritic cell maturation. J. Immunol. 169, 4770-4777 (2002).
55. Lutz, M.B. & Schuler, G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 23, 445-449 (2002).
56. Leslie, D.S. et al. CD1-mediated γ/δ T cell maturation of dendritic cells. J. Exp. Med. 196, 1575-1584 (2002).
57. Kitamura, H. et al. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189, 1121-1128 (1999).
58. Beckman, E.M. et al. CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family. J. Immunol. 157, 2795-2803 (1996).
59. Stenger, S. et al. Differential effects of cytolytic T cell subsets on intracellular infection. Science 276, 1684-1687 (1997).
60. Stenger, S. et al. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282, 121-125 (1998).
61. Kawashima, T. et al. Major CD8 T cell response to live BCG is mediated by CD1 molecules. J. Immunol. in the press.
62. Dascher, C.C. et al. Conservation of a CD1 multigene family in the guinea pig. J. Immunol. 163, 5478-5488 (1999).
63. Hiromatsu, K. et al. Induction of CD1-restricted immune responses in guinea pigs by immunization with mycobacterial lipid antigens. J. Immunol. 169, 330-339 (2002).
64. Dascher, C.C. et al. Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis. Int. Immunol. in the press.
65. Carnaud, C. et al. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163, 4647-4650 (1999).
66. α14 natural killer T cells mediate protection against murine malaria. Proc. Natl. Acad. Sci. USA 97, 8461-8466 (2000).
67. + natural killer T cells by α-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans. Infect. Immun. 69, 213-220 (2001).
68. Exley, M.A. et al. CD1d-reactive T cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus. J. Leukoc. Biol. 69, 713-718 (2001).
69. Nieuwenhuis, E.E. et al. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat. Med. 8, 588-593 (2002).
70. Chackerian, A., Alt, J., Perera, V. & Behar, S.M. Activation of NKT cells protects mice from tuberculosis. Infect. Immun. 70, 6302-6309 (2002).
71. Duthie, M.S. & Kahn, S.J. Treatment with α-galactosylceramide before Trypanosoma cruzi infection provides protection or induces failure to thrive. J. Immunol. 168, 5778-5785 (2002).
72. + T cells and amplification of antiviral immune responses to respiratory syncytial virus. J. Virol. 76, 4294-4303 (2002).
73. Schofield, L. et al. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 283, 225-229 (1999).
74. Molano, A. et al. Cutting edge: the IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: exploring the role of GPIs in NK T cell activation and antimalarial responses. J. Immunol. 164, 5005-5009 (2000).
75. Procopio, D.O. et al. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway. J. Immunol. 169, 3926-3933 (2002).
76. Apostolou, I. et al. Murine natural killer T (NKT) cells contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc. Natl. Acad. Sci. USA 96, 5141-5146 (1999).
77. Mempel, M. et al. Natural killer T cells restricted by the monomorphic MHC class 1b CD1d1 molecules behave like inflammatory cells. J. Immunol. 168, 365-371 (2002).
78. Kumar, H., Belperron, A., Barthold, S.W. & Bockenstedt, L.K. Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi. J. Immunol. 165, 4797-4801 (2000).
79. Duthie, M,S. et al. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein. Infect. Immun. 70, 36-48 (2002).
80. α14 NKT cells in IL-12-mediated rejection of tumors. Science 278, 1623-1626 (1997).
81. Toura, I. et al. Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with α-galactosylceramide. J. Immunol. 163, 2387-2391 (1999).
82. Fujii, S., Shimizu, K., Kronenberg, M. & Steinman, R.M. Prolonged IFN-γ-producing NKT response induced with α-galactosylceramide-loaded DCs. Nat. Immunol. 3, 867-874 (2002).
83. Hakomori, S. Glycosylation defining cancer malignancy: new wine in an old bottle. Proc. Natl. Acad. Sci. USA 99, 10231-10233 (2002).
84. Ostrand-Rosenberg, S. et al. Resistance to metastatic disease in STAT6-deficient mice requires hemopoietic and nonhematopoietic cells and is IFN-γ dependent. J. Immunol. 169, 5796-5804 (2002).
85. Terabe, M. et al. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat. Immunol. 1, 515-520 (2000).
86. Smyth, M.J. et al. Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med. 191, 661-668 (2000).
87. Smyth, M.J., Crowe, N.Y. & Godfrey, D.I. NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma. Int. Immunol. 13, 459-463 (2001).
88. Crowe, N.Y., Smyth, M.J. & Godfrey, D.I. A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas. J. Exp. Med. 196, 119-127 (2002).
89. Zheng, Z., Venkatapathy, S., Rao, G. & Harrington, C.A. Expression profiling of B cell chronic lymphocytic leukemia suggests deficient CD1-mediated immunity, polarized cytokine response, altered adhesion and increased intracellular protein transport and processing of leukemic cells. Leukemia 16, 2429-2437 (2002).
90. Sieling, P.A. et al. Human double-negative T cells in systemic lupus erythematosus provide help for IgG and are restricted by CD1c. J. Immunol. 165, 5338-5344 (2000).
91. H2 bias of natural killer T cells. Nature 413, 531-534 (2001 ).
92. Singh, A.K. et al. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 194, 1801-1811 (2001).
93. Jahng, A.W. et al. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J. Exp. Med. 194, 1789-1799 (2001).
94. +-like thymocytes in the NOD mouse. Eur. J. Immunol. 26, 2989-2998 (1996).
95. Falcone, M., Yeung, B., Tucker, L., Rodriguez, E. & Sarvetnick, N. A defect in interleukin 12-induced activation and interferon γ secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus. J. Exp. Med. 190, 963-972 (1999).
96. Hammond, K.J. et al. CD1d-restricted NKT cells: an interstrain comparison. J. Immunol. 167, 1164-1173 (2001).
97. - T-cell deficiency and IDDM in NOD/Lt mice. Diabetes 46, 572-582 (1997).
98. α281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188, 1831-1839 (1998).
99. Sharif, S. et al. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune type 1 diabetes. Nat. Med. 7, 1057-1062 (2001).
100. Hong, S. et al. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 7, 1052-1056 (2001).
101. Naumov, Y.N. et al. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl. Acad. Sci. USA 98, 13838-13843 (2001).
102. Shi, F.D. et al. Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse. Proc. Natl. Acad. Sci. USA 98, 6777-6782 (2001).
103. Wang, B., Geng, Y.B. & Wang, C.R. CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes. J. Exp. Med. 194, 313-320 (2001).
104. Beaudoin, L., Laloux, V., Novak, J., Lucas, B. & Lehuen, A. NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic β cells. Immunity 17, 725-736 (2002).
105. αQ T cells from identical twins discordant for type I diabetes. Proc. Natl. Acad. Sci. USA 97, 7411-7416 (2000).
106. αQ T cells in type 1 diabetes. Nature 391, 177-181 (1998); erratum Nature 399, 84 (1999).
107. Lee, P.T. et al. Testing the NKT cell hypothesis of human IDDM pathogenesis. J. Clin. Invest. 110, 793-800 (2002).
108. Sonoda, K.H., Exley, M., Snapper, S., Balk, S.P. & Stein-Streilein, J. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J. Exp. Med. 190, 1215-1226 (1999).
109. Sonoda, K.H. & Stein-Streilein, J. CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance. Eur. J. Immunol. 32, 848-857 (2002).
110. Sonoda, K.H. et al. NK T cell-derived IL-10 is essential for the differentiation of antigen-specific T regulatory cells in systemic tolerance. J. Immunol. 166, 42-50 (2001).